Patent Assignment
Reel/Frame 019208/0960
Change of Name
Recorded: 2007-04-25
Pages: 4
Assignor
GENAISSANCE PHARMACEUTICALS, INC.
Executed: 2006-12-22
Assignee
COGENICS, INC.
FIVE SCIENCE PARK, NEW HAVEN, CONNECTICUT, 06511
Covered Properties
(26)
CHRNA2 genetic markers associated with galantamine response
Application:
10/887,650 →
Publication:
US 2005/0048543
NTRK1 genetic markers associated with age of onset of Alzheimer's Disease
Application:
10/962,756 →
Publication:
US 2005/0255488
LRPAP1 genetic markers associated with galantamine response
Application:
10/972,764 →
Publication:
US 2005/0260613
EPHX2 Genetic markers associated with galantamine response
Application:
10/972,766 →
Publication:
US 2005/0250118
NTRK1 genetic markers associated with progression of Alzheimer's disease
Application:
10/993,483 →
Publication:
US 2006/0166219
NTRK2 genetic markers associated with progression of Alzheimer's disease
Application:
10/993,509 →
Publication:
US 2005/0250121
APOA4 genetic markers associated with progression of Alzheimer's disease
Application:
10/993,514 →
Publication:
US 2005/0250122
CHRNA9 genetic markers associated with progression of Alzheimer's disease
Application:
10/993,516 →
Publication:
US 2005/0255492
CDK5 Genetic Markers Associated with Galantamine Response
SLC5A7 genetic markers associated with age of onset of Alzheimer's disease
Application:
11/005,030 →
Publication:
US 2005/0255495
APOE genetic markers associated with age of onset of Alzheimer's disease
Application:
11/034,771 →
Publication:
US 2005/0277129
APOC1 genetic markers associated with age of onset of Alzheimer's Disease
Application:
11/035,105 →
Publication:
US 2005/0255498
LDLR genetic markers associated with age of onset of Alzheimer's Disease
Application:
11/035,114 →
Publication:
US 2006/0154265
CHRNA2 genetic markers associated with galantamine response
Application:
60/486,331 →
NTRK1 genetic markers associated with age of onset of Alzheimers's disease
Application:
60/511,247 →
EPHX2 genetic markers associated with galantamine response
Application:
60/515,378 →
LRPAP1 genetic markers associated with galantamine response
Application:
60/515,414 →
APOA4 genetic markers associated with progression of alzheimer's disease
Application:
60/524,467 →
NTRK1 genetic markers associated with progression of Alzheimer's disease
Application:
60/524,636 →
NTRK2 genetic markers associated with progression of Alzheimer's disease
Application:
60/524,637 →
CHRNA9 genetic markers associated with progression of Alzheimer's disease
Application:
60/524,638 →
SLC5A7 genetic markers associated with age of onset of Alzheimer's disease
Application:
60/529,999 →
CDK5 genetic markers associated with galantamine response
Application:
60/530,000 →
APOE genetic markers associated with age of onset of Alzheimer's disease
Application:
60/538,590 →
APOC1 genetic markers associated with age of onset of Alzheimer's disease
Application:
60/538,606 →
LDLR genetic markers associated with age of onset of Alzheimer's disease
Application:
60/538,607 →
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 13, 2004
From: COHEN, NADINE
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 014986/0401 →
Assignment of Assignor's Interest
Aug 13, 2004
From: JANSSEN PHARMACEUTICA NV
To: GENAISSANCE PHARMACEUTICALS
Reel/Frame 014986/0475 →
Assignment of Assignor's Interest
Sep 24, 2004
From: JANSSEN PHARMACEUTICA NV
To: GENAISSANCE PHARMACEUTICALS
Reel/Frame 015181/0494 →
Assignment of Assignor's Interest
Sep 24, 2004
From: COHEN, NADINE; AERSSENS, JEROEN; OZDEMIR, VURAL
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 015181/0406 →
Assignment of Assignor's Interest
Oct 14, 2004
From: JUDSON, RICHARD S.
To: GENAISSANCE PHARMACEUTICALS
Reel/Frame 015250/0207 →
Assignment of Assignor's Interest
Oct 14, 2004
From: AERSSENS, JEROEN; OZDEMIR, VURAL
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 015250/0200 →
Assignment of Assignor's Interest
Dec 17, 2004
From: ATHANASIOU, MARIA; BRAIN, CARLOS; DAIN, BRADLEY; DENTON, R. REX
To: GENAISSANCE PHARMACEUTICALS
Reel/Frame 015467/0632 →
Assignment of Assignor's Interest
Dec 28, 2004
From: JANSSEN PHARMACEUTICA NV
To: GENAISSANCE PHARMACUTICALS
Reel/Frame 015493/0844 →
Assignment of Assignor's Interest
Dec 28, 2004
From: COHEN, NADINE; AERSSENS, JEROEN; OZDEMIR, VURAL
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 015493/0828 →
Assignment of Assignor's Interest
Jan 10, 2005
From: COHEN, NADINE; AERSSENS, JEROEN; OZDEMIR, VURAL
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 015542/0700 →
Assignment of Assignor's Interest
Jan 10, 2005
From: JANSSEN PHARMACEUTICA NV
To: GENAISSANCE PHARMACEUTICALS
Reel/Frame 015542/0848 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded on Reel 015493, Frame 0844. Assignor Hereby Confirms the Assignment of the Entire Interest.
Feb 3, 2005
From: JANSSEN PHARMACEUTICA NV
To: GENISSANCE PHARMACEUTICALS
Reel/Frame 015655/0363 →
Assignment of Assignor's Interest
Sep 19, 2005
From: JANSSEN PHARMACEUTICA NV
To: GENAISSANCE PHARMACEUTICALS
Reel/Frame 016562/0668 →
Assignment of Assignor's Interest
Sep 19, 2005
From: COHEN, NADINE; AERSSENS, JEROEN; OZDEMIR, VURAL
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 016552/0660 →
Assignment of Assignor's Interest
Dec 19, 2005
From: ATHANASIOU, MARIA; BRAIN, CARLOS; DAIN, BRADLEY; DENTON, R. REX
To: GENAISSANCE PHARMACEUTICALS, INC.
Reel/Frame 016916/0452 →
Assignment of Assignor's Interest
May 18, 2007
From: COGENICS, INC.
To: PGXHEALTH, LLC
Reel/Frame 019315/0249 →
Security Agreement
May 14, 2013
From: TRANSGENOMIC, INC.
To: THIRD SECURITY SENIOR STAFF 2008 LLC
Reel/Frame 030408/0795 →